![Biology / Medicine / Biotechnology / Specialty drugs / Peptide hormones / Recombinant proteins / Eli Lilly and Company / Trastuzumab / Kiran Mazumdar-Shaw / Biosimilar / Biocon / Biopharmaceutical Biology / Medicine / Biotechnology / Specialty drugs / Peptide hormones / Recombinant proteins / Eli Lilly and Company / Trastuzumab / Kiran Mazumdar-Shaw / Biosimilar / Biocon / Biopharmaceutical](https://www.pdfsearch.io/img/25cf9d1e91c64da0313a40613185add5.jpg) Date: 2016-08-03 03:39:33Biology Medicine Biotechnology Specialty drugs Peptide hormones Recombinant proteins Eli Lilly and Company Trastuzumab Kiran Mazumdar-Shaw Biosimilar Biocon Biopharmaceutical | | Biocon Limited: Q1 FY17 Earnings Call Transcript July 22, 2016 Participants from Biocon’s Senior Management Team Kiran Mazumdar Shaw: Chairperson and Managing Director Arun Chandravarkar: CEO & Jt. Managing DirectorAdd to Reading ListSource URL: www.biocon.comDownload Document from Source Website File Size: 99,85 KBShare Document on Facebook
|